BROOKFIELD Corp ON reduced its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 35.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 826,908 shares of the real estate investment trust's stock after selling 451,711 shares during the period. BROOKFIELD Corp ON owned approximately 0.12% of Healthpeak Properties worth $16,720,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in DOC. TCTC Holdings LLC boosted its holdings in shares of Healthpeak Properties by 124.3% in the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock worth $27,000 after acquiring an additional 751 shares during the period. Brooklyn Investment Group boosted its holdings in shares of Healthpeak Properties by 198.9% in the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock worth $27,000 after acquiring an additional 873 shares during the period. Future Financial Wealth Managment LLC bought a new position in shares of Healthpeak Properties in the first quarter worth $30,000. S.A. Mason LLC lifted its holdings in shares of Healthpeak Properties by 160.9% in the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after buying an additional 925 shares in the last quarter. Finally, Dagco Inc. purchased a new stake in shares of Healthpeak Properties in the first quarter worth about $30,000. 93.57% of the stock is owned by institutional investors.
Healthpeak Properties Trading Up 1.2%
Shares of DOC opened at $18.16 on Friday. The firm's 50 day simple moving average is $17.76 and its 200 day simple moving average is $18.21. The company has a market capitalization of $12.62 billion, a P/E ratio of 75.67, a P/E/G ratio of 2.31 and a beta of 1.07. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. Healthpeak Properties, Inc. has a 1-year low of $16.63 and a 1-year high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. The business had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. Healthpeak Properties's quarterly revenue was down .2% on a year-over-year basis. During the same period last year, the firm posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently disclosed a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were given a dividend of $0.1017 per share. The ex-dividend date was Monday, August 18th. This represents a c) annualized dividend and a dividend yield of 6.7%. Healthpeak Properties's dividend payout ratio is 508.33%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $18.00 price target (down from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Robert W. Baird set a $21.00 price target on shares of Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Scotiabank downgraded shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their price target for the stock from $21.00 to $19.00 in a report on Tuesday, July 29th. Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Finally, Morgan Stanley decreased their target price on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a research note on Friday, August 22nd. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and an average price target of $21.50.
View Our Latest Report on Healthpeak Properties
Insider Activity at Healthpeak Properties
In other news, CEO Scott M. Brinker acquired 2,930 shares of Healthpeak Properties stock in a transaction dated Thursday, July 31st. The shares were purchased at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the transaction, the chief executive officer owned 210,416 shares of the company's stock, valued at $3,589,696.96. This trade represents a 1.41% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. In the last 90 days, insiders bought 8,783 shares of company stock worth $150,129. 0.23% of the stock is currently owned by corporate insiders.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.